Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Tao, Sally Schott, V. Prasad (2019)
The Tradeoff of Cancer Drug Regulatory Policy: Faster Approvals for One Means Less Knowledge for Another.The American journal of medicine, 132 3
J. Beaver, R. Pazdur (2021)
"Dangling" Accelerated Approvals in Oncology.The New England journal of medicine
A. Haslam, J. Gill, V. Prasad (2020)
Oncology Drug Advisory Committee Recommendations and the US Food and Drug Administration's Actions.Mayo Clinic proceedings, 95 2
This Viewpoint describes the implications of US Food and Drug Administration changes to postmarketing requirements.
JAMA Oncology – American Medical Association
Published: Nov 8, 2021
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.